At 9.10 AM Symphony had a pre-opening move of 10 per cent north with an increase from the previous close of Rs 955 to Rs 1050 today.

At 9.30 AM Repro had an opening move of 8.77 per cent north with an increase from the previous close of Rs 436 to Rs 474 today. 

Saurabh Mukherjea is the Founder and Chief Investment Officer of Marcellus Investment Managers. In a recent interview, he has discussed what companies and themes he buys in the current fall.

At 9.20 AM Future Enterprises had an opening move of 14.5 per cent north with an increase from the previous close of Rs 9.59 to Rs 11 today.

Future Supply Chain Solutions, Future Retail and Alembic, Eveready are the opening movers in smallcap. 

While markets opened much higher, as of 12.30 PM, the BSE Smallcap index was trading up by 3.57 per cent.   

Polyester films manufacturing company, Garware Hi-Tech Films has rallied more than 20 per cent in today’s trading session. It opened at Rs 635 and touched a day’s high of Rs 784. 

Sanjeev Bikchandani grew up in a typical middle-class household. His father was a low-paid doctor at a government hospital, and his mother was a housewife. In 1984, he joined Lintas as an Accounts Executive after completing his Bachelor of Arts with a focus in Economics. 

At 9.10 am, Stylam Industries had a pre-opening move of 16.3 per cent north with an increase from its previous close of Rs 902 to Rs 1,005 today morning.

At 9.07 AM Kennametal India had a pre-opening move of 7.15 per cent north with an increase from the previous close of Rs 1,891 to Rs 2,026 today morning. 

This small-size building material company, Everest Industries gained more than 15 per cent in the first half of the trading session.

This small-size Battery manufacturing company, Eveready Industries gained more than 10 per cent in the first half of the trading session.

It has been in a downtrend for the past one month, declining more than 25 per cent from Rs 1,958 on January 17, 2022, to Rs 1,451 on February 14, 2022.

While markets opened marginally higher, as of 12.30 PM, BSE 500 was 1.13 per cent up.   

While markets opened with a steep fall with a negative global cue, as of 12.30 PM, BSE 500 was 2.07 per cent up.  

While markets opened flat, as of 12.30 PM, BSE 500 was 0.70 per cent up. 

BSE 500 has opened with a gap up of 0.8 per cent in the morning session. In the mid-day trading, it is maintaining the momentum- at 12.30 PM, BSE 500 was 0.85 per cent up. TV 18 Broadcast, Spandana Sphoorty Financial, Coal India are the top gainers.

In mid-day trading, BSE Smallcap was down by 0.95 per cent. However, Camlin Fine Sciences, Max Healthcare Institute, Polyplex Corporation are up as of noon. 

In the afternoon deals, Sensex was trading down by 1.12 per cent. Despite a large selling in the market, Bank of Baroda, GNFC, Affle has gained good momentum today with a fundamental reason behind it. The snapshot of it is discussed below. 

In the afternoon deals, Sensex was trading marginally down by 0.25 per cent. Torrent Power, HG Infra, Sadhana Nitro Chem gained good momentum today with a fundamental reason behind it. The snapshot of it is discussed below

At 1 PM, while BSE 500 is down by 0.5 per cent, Blue Star, MAS Financial Services, Deepak Fertilisers and Petrochemicals Corporation were among the top 10 gainers of BSE 500.

Nifty IT has gained momentum with a few announcements for the technology sector in today’s Budget announcement. At the time of the closing bell, IT stocks such as HCL, Infosys, and Tech Mahindra climbed 3 per cent, 2.1 per cent & 1.8 per cent, respectively.

At the time of the closing bell, the shares of select companies such as Oberoi Realty, DLF, and Sobha were up by 5.8 per cent, 4.25 per cent & 2 per cent, respectively. 

One of the leading manufacturers of consumer products company Crompton has announced its Q3 results on Friday post market hours. Today, Nifty got momentum with positive global cues, whereas Crompton was able to ride the momentum with their Q3 results

A leading generic API company Laurus Labs has announced its Q3 results yesterday. Shares of the company were in sideways for three months since November. But from yesterday's afternoon (January 27) trading session, it is up more than 13 per cent with the results being published just before the market close.

Leading drug maker Cipla has announced its Q3 results a few days back. Ahead of the results, shares of the company got an upward momentum and gained 3.5 per cent in three trading days. Post-result, that is today it gained a decent 2.2 per cent that too when the overall market sentiment is bearish. 

It had a good rally with the Q3 result anticipation. The stock was up 15.78 per cent for the month till yesterday. Since Q3 results didn’t meet the expectation, the stock tumbled 15 per cent in the morning trading session. 

Smallcap stocks rally very fast as well as fall at the same pace. Because of disappointing numbers market punished the stock with a steep fall in price. In Q3FY22, revenue is down 14 per cent and net profit declined 44 per cent on YoY with high base effect and extreme margin pressure.

It had a good rally with the Q3 result anticipation, 13.75 per cent up for the month, 3.75 per cent up for the day. It is expected to be a buzzing stock tomorrow because of the impressive numbers.

The acquisition will strengthen Tech Mahindra’s capabilities in Digital Experience Solutions: Learning & development, marketing, instructional design; Engineering: Cloud & automation, BI & analytics, and technical support services. 

HCL already owns an 80.4 per cent stake in the company and is buying out the minority partner who holds the balance 19.6 per cent stake in the company. The cost of acquisition is USD 100.2M (Rs 750 crore) for the remaining 19.6 per cent ownership of HCL Technologies SEP Holdings Inc.

Cipla Limited announced today that it has been granted Emergency Use Authorization (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in the country. Cipla plans to launch Molnupiravir under the brand name Cipmolnu. Molnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of mild-to-moderate COVID-19 at high risk of developing severe disease.

IndusInd Bank has joined hands with the National Payments Corporation of India (NPCI) for offering real-time cross-border remittances to India using UPI IDs, for its Money Transfer Operator (MTO) partners.

The TVS Apache RTR 165 RP motorcycle gets an advanced 164.9 cc single-cylinder 4 valve engine that churns out 19.2 PS at 10,000 rpm and 14.2 Nm torque at 8,750 rpm.

Have you ever visited Ibaco and tasted delicious ice cream or, at the very least, icone, ibar from Arun ice cream? If you don't, you're missing out on some tasty ice cream.

HCL Technologies (HCL) signed a five-year agreement with CEMEX, a global construction materials company, to deliver the next generation of employee services enabled by digital transformation, increased automation and near real-time analytics as part of the CEMEX “Working Smarter Program”.

Macrotech Developers Limited (Lodha), one of the leading real estate developers received an exceptional score in S&P Global Corporate Sustainability Assessment (CSA). Following a thorough evaluation across the company’s Environmental, Social, and Governance (ESG) dimensions, Lodha scored 58 out of 100 in the 2021 S&P Global Corporate Sustainability Assessment. This was Macrotech Developers first attempt at the assessment.

The FDA approval was based on a New Drug Application (NDA) submitted under the 505(b)(2) filing pathway. Lanreotide injection is supplied in 60 mg/0.2 mL, 90 mg/0.3 mL, and 120 mg/0.5 mL single-dose prefilled syringes. It is used for treating patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). 

The Fed will speed up a reduction in bond purchases to US$30 billion a month so that the programme could end in March instead of the original plan of June”. This reduction in a bond purchase is called tapering.

Zomato is making a primary investment to acquire a minority stake in Curefit and will purchase one share of the company at Rs 483.62. The total percentage of shareholding would be 6.38 per cent of the fully diluted basis, the authorized share capital of Curefit is Rs 1,264.11 crore

Ramkrishna Forgings Limited, one of the leading suppliers of rolled, forged and machined products has won a domestic order worth Rs 9 crore (USD 1.2 million) from a Multinational Oil & Gas Tier-1 component supplier in India.

This will give a strong impetus to India's manufacturing competitiveness and leverage the production-linked incentive (PLI) by the Government of India. Acer will bring in the global know-how and processes to manufacture high-tech electronic products in the laptops category which will be implemented through Dixon’s facilities.

TVS Motor Company, one of the largest manufacturers of two-wheelers and three-wheelers in the world, today announced that they have signed a Memorandum of Understanding (MOU) with the Government of Tamil Nadu for investment in Future Technologies and Electric Vehicle.

Laurus Labs has signed an investment agreement with Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an advanced cell and gene therapy company to acquire a 26.62 per cent stake (fully diluted basis) for a cash consideration of approximately Rs 46 crore, subject to the fulfilment of certain conditions. 

Biocon Biologics Ltd, a subsidiary of Biocon Ltd, and Viatris Inc confirm that Insulin Glargine injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 per cent off the cash price of comparable long-acting insulins purchased at Walgreens. 

Zydus Cadila has received final approval from the USFDA to market Nelarabine Injection 250MG/50ML in the United States. Zydus Pharmaceuticals USA Inc (Zydus) was granted a Competitive Generic Therapy (CGT) designation for Nelarabine Injection, Single-Dose Vial. 

The Phoenix Mills Limited (PML) and Canada Pension Plan Investment Board (CPP Investments) today announced a new joint venture to develop an office-led mixed-use asset in Lower Parel, Mumbai. The asset forms bigger mixed-use development at Phoenix Palladium, Mumbai

Tata Consultancy Services (TCS), a leading global IT giant that provides services, consulting, and business solutions for organizations, announced a strategic transformation engagement with Zebra Technologies Corporation. 

Q2 result: Revenue delined 18.6 per cent on YoY basis, Net profit declined 248 per cent on YoY bais, company had weak margins in Q2 quarter due to increase in mployee benefit expenses.

Britannia reported a 23 per cent year-on-year decline in its consolidated net profit to Rs 384.22 crore for the quarter ended September, which was below analysts’ expectations. 

Zydus Cadila has received an order to supply one crore doses of ZyCoV-D, the world’s first Plasmid DNA Vaccine, to the Government of India at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose

This is a sequential growth over the volume sales in the month of September, when Hero MotoCorp dispatched 530,346 units of motorcycles and scooters, indicating a gradual recovery in the economy

Tata Power and Tata Steel, the two flagship companies of the Tata Group, have come together to develop grid-connected solar plants in Jharkhand and Odisha.

The company's revenue from operations rose 13 per cent to Rs 14,844 crore from Rs 13,147 crore in the same quarter last year. Net Profit rose 22 per cent to Rs. 3,714 crore on a YoY basis. 

In Q2FY22, on a consolidated basis, the company’s revenue stood at Rs 2,843 crore, an increase of 35 per cent on a YoY basis. EBIT increased by 19 per cent YoY to Rs 570 crore. However, the EBIT margin for the quarter contracted by 270 bps YoY and stood at 19.58 per cent

According to the report, the Department of Telecommunications (DoT) has reached out to mobile operators seeking their response on whether they want to opt for a four-year moratorium on spectrum payments and adjusted gross revenue (AGR) dues.

The first is the development of six lane Baunsaguar- Baraja section of NH-130 CD road from 293.0 km to 338.500 km under the Raipur-Visakhapatnam Economic Corridor in the state of Odisha on HAM (Package OD-6). The NHAI bid project cost is Rs 958.98 crore and the HG Infra bid project cost is Rs 1,123.11 crore. 

Net sales in Q2 FY22 increased by 8.8 per cent QoQ and 25.6 per cent YoY to Rs.3,767 crore against Rs 2,998 crore in the previous year same quarter. EBIT increased by 14.1 per cent QoQ and 8.8 per cent YoY to Rs 648 crore against Rs 595 crore in the previous year same quarter.

The reason might be profit booking, as the stock has been rallying for quite a long time, 20 per cent up in last 5 days, 70 per cent up in last 6 months. The stock looks expensive, it is trading at a P/E multiple of 250, and people didn’t feel the price matches the fundamentals, whereas the industry P/E is 158. 

Mastek Ltd has turned to become a multibagger for Sunil Singhania. He is quite bullish on this mid-cap IT company for quite a long time. In March 2020 quarter he increased the stake from 2.6 per cent to 5.6 per cent. His portfolio worth of this stock would be somewhere around Rs 27 crore in March 2020, his current holding has increased to Rs 474 crore due to 18x times increase in stock price.

Indian business magnate Mukesh Ambani is well on his way to join the extremely exclusive club with a net worth of USD 100 billion or more to their name. Ambani would be the 11th current member, first Indian and second non-American in the club in its present form. 

COPD is a long-term condition that causes inflammation in the lungs, damaging the lung tissue and narrowing the airways, all of which make breathing difficult. Studies show that close to 2.5 million people suffer from COPD in Spain.

As we all know Rakesh Jhunjhunwala is extremely bullish on this jewellery company Titan, half of his portfolio is invested in it, with a holding value worth Rs 10,115 crore. This stock has rallied from Rs 1,560 to Rs 2,350 with a 52 per cent return in less than seven months, which helped him make huge money. 

Gautam Adani and family earned Rs 1,002 crore a day in the last one year to quadruple their wealth to Rs 5.05 lakh crore from Rs 1.04 lakh crore a year ago, making him the second richest man in Asia, according to a list by research company Hurun India. 

The Company registered a sales volume of 427,387 Ton in Q2FY22 (+15 per cent QoQ/-11 per cent YoY), recovered sequentially as the construction activity started to pick up after the Covid second wave which had hit the country in Q1.

There is a small link between cricket and the stock market.

These days watching T20 is fun, thrilling, and exciting, likewise trading in the stock market is also very interesting, and quick money can be made out of it.